Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors

Clinical trial NCT06128148 · RECRUITING

Trial details

NCT number: NCT06128148
Sponsor: Guangzhou JOYO Pharma Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Protein Kinase Inhibitors Other Protocol Specified Criteria Lung Neoplasms Brain Neoplasms

Start date: 2022-05-04
Primary completion: 2026-06-30
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.